Seasonal influenza vaccine and increased risk of pandemic A/H1N1‐related illness: first detection of the association in British Columbia, Canada. - Wikidata - wikimedia - TriplyDB

Seasonal influenza vaccine and increased risk of pandemic A/H1N1‐related illness: first detection of the association in British Columbia, Canada.

Seasonal influenza vaccine and increased risk of pandemic A/H1N1‐related illness: first detection of the association in British Columbia, Canada.

http://www.wikidata.org/entity/Q30394369

about

Immunogenicity and cross-reactivity of 2009-2010 inactivated seasonal influenza vaccine in US adults and elderly Randomized controlled ferret study to assess the direct impact of 2008-09 trivalent inactivated influenza vaccine on A(H1N1)pdm09 disease risk Hospital capacity and management preparedness for pandemic influenza in Victoria.Two years after pandemic influenza A/2009/H1N1: what have we learned?Difference in immune response in vaccinated and unvaccinated Swedish individuals after the 2009 influenza pandemic Partial protection against 2009 pandemic influenza A (H1N1) of seasonal influenza vaccination and related regional factors: Updated systematic review and meta-analyses.Interval Between Infections and Viral Hierarchy Are Determinants of Viral Interference Following Influenza Virus Infection in a Ferret Model.Enhanced risk of illness during the 1918 influenza pandemic after previous influenza-like illnesses in three military populations.Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada.Non-neutralizing antibodies induced by seasonal influenza vaccine prevent, not exacerbate A(H1N1)pdm09 disease.Vaccination against seasonal influenza A/H3N2 virus reduces the induction of heterosubtypic immunity against influenza A/H5N1 virus infection in ferrets Predictors of influenza a molecular viral shedding in Hutterite communities.Field effectiveness of pandemic and 2009-2010 seasonal vaccines against 2009-2010 A(H1N1) influenza: estimations from surveillance data in France.Annual vaccination against influenza virus hampers development of virus-specific CD8⁺ T cell immunity in children Towards universal influenza vaccines?Seroprevalence and severity of 2009 pandemic influenza A H1N1 in Taiwan.Post-pandemic seroprevalence of pandemic influenza A (H1N1) 2009 infection (swine flu) among children <18 years in Germany.Transmission dynamics and risk factors for pandemic H1N1-related illness: outbreak investigation in a rural community of British Columbia, Canada Prospective hospital-based case-control study to assess the effectiveness of pandemic influenza A(H1N1)pdm09 vaccination and risk factors for hospitalization in 2009-2010 using matched hospital and test-negative controls Seroconversion to seasonal influenza viruses after A(H1N1)pdm09 virus infection, Quebec, Canada The potential effect of temporary immunity as a result of bias associated with healthy users and social determinants on observations of influenza vaccine effectiveness; could unmeasured confounding explain observed links between seasonal influenza v Characterization of immune responses induced by immunization with the HA DNA vaccines of two antigenically distinctive H5N1 HPAIV isolates Long-term immunogenicity of the pandemic influenza A/H1N1 2009 vaccine among health care workers: influence of prior seasonal influenza vaccination.Pandemic influenza A(H1N1)pdm09: risk of infection in primary healthcare workers.Seasonal influenza and vaccine herd effect.Options and obstacles for designing a universal influenza vaccine Surveillance and vaccine effectiveness of an influenza epidemic predominated by vaccine-mismatched influenza B/Yamagata-lineage viruses in Taiwan, 2011-12 season Animal models for influenza viruses: implications for universal vaccine development Mid-Season Estimates of Influenza Vaccine Effectiveness against Influenza A(H3N2) Hospitalization in the Elderly in Quebec, Canada, January 2015 Immunity against heterosubtypic influenza virus induced by adenovirus and MVA expressing nucleoprotein and matrix protein-1.Animal models to assess the toxicity, immunogenicity and effectiveness of candidate influenza vaccines.A novel approach for addressing diseases not yielding to effective vaccination? Immunization by replication-competent controlled virus.Partial Protection against Porcine Influenza A Virus by a Hemagglutinin-Expressing Virus Replicon Particle Vaccine in the Absence of Neutralizing Antibodies.Seeking help: B cells adapting to flu variability.Cross-Protective Immune Responses Induced by Sequential Influenza Virus Infection and by Sequential Vaccination With Inactivated Influenza Vaccines

P2860

Q21560857-6F553779-BC71-4A4D-AE54-E500350CF7E8 Q27330166-C2780215-A6B9-4074-ABD8-0C1279C955E8 Q30210612-387B5D61-45ED-41D9-96F4-EF8F2344DD69 Q30224656-75B140D7-5DCF-498F-A7C5-D49EB0FB00CD Q30363471-FF5606AA-4189-4773-B278-9F56F56D3678 Q30371873-6F457780-344A-412D-9C5A-882F8E744637 Q30374400-CAD26FB3-1138-469B-99D9-081A5ECD4AB8 Q30385429-440C841C-032F-48CD-BB2F-2D9E9F6B65C6 Q30388012-1E77D451-404D-4647-9B55-DA1325FA5F1D Q30395259-DBF0F190-0A9A-468E-A179-76F7E1A14CB7 Q30398516-758647B4-52B6-4EC0-BCD3-37A26CBADFB8 Q30398711-22CB2A80-8642-4CF8-BB21-204CE3FC6945 Q30402693-184ABA5C-C5D8-4ED1-BD1D-38CFE127BAED Q30406576-8B494D4A-A1B9-47BE-A768-2D7C381D2F39 Q30406748-8CB82106-25C7-4B3B-98DC-80A37341DC4B Q30406971-9512DA0E-0ADD-4BA7-ADB5-18C29E571751 Q30407047-8B20E59A-1B8D-4B8A-91C1-6631F4745675 Q30413763-499DFF83-DFB9-4E67-A14E-A736440274DD Q30417417-3556A4C2-E9C3-454D-A5D6-67DF4FDC9296 Q30418193-20320C6E-EC86-4940-BF2D-9C719915F948 Q30418277-7BCFAD21-0E5E-4D29-B839-690364FE4751 Q30420017-9A8AE7D9-C8B8-49F0-8235-30B1F8DC5D9D Q30426547-ED1B06C0-E3B6-4D4C-9FD8-D0257BB82608 Q30431452-7CBCA2FA-5ECA-4D25-85D1-9F65AADC0171 Q33850478-F77F0998-FFF2-4600-8627-24CBFF551C75 Q34102290-470C6D0C-8C1B-4EB4-997C-D8E4E48670E9 Q34614814-7293EEE5-928C-46A5-9CA2-9F8BB0E14918 Q34809686-EC277444-F208-4157-AD0E-0363668C76E9 Q35705382-BE9427D0-FCCA-485A-A8EF-F07B9FB1A0D3 Q36679099-1593BA4C-DFD7-4A9C-91DC-C666397A01F4 Q37900305-BDF7FEEC-0325-4484-BCF0-0F2DC6D55F30 Q38353693-A67F72EC-CEF3-4651-A6F7-6FD15727478D Q38436945-088A4302-96F3-43FC-A3EC-B35A39016349 Q42201392-8294892E-2249-4213-AD81-8683D2F24465 Q57816687-F9EC1DAF-3A0D-455C-B36F-7A5D41DD56BF

P2860

Seasonal influenza vaccine and increased risk of pandemic A/H1N1‐related illness: first detection of the association in British Columbia, Canada.

http://www.wikidata.org/entity/Q30394369

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Seasonal influenza vaccine and ...... n in British Columbia, Canada.

@ast

Seasonal influenza vaccine and ...... n in British Columbia, Canada.

@en

type

label

Seasonal influenza vaccine and ...... n in British Columbia, Canada.

@ast

Seasonal influenza vaccine and ...... n in British Columbia, Canada.

@en

prefLabel

Seasonal influenza vaccine and ...... n in British Columbia, Canada.

@ast

Seasonal influenza vaccine and ...... n in British Columbia, Canada.

@en

P1433

Q30394369-A050085D-F633-41A2-AF16-D0A20AE6EE87

P1476

Q30394369-B0966AC9-5EA2-4495-803D-6F1DF4E449AF

P2093

Q30394369-458BDD30-98EA-4449-8B8F-D42F9FE96EDB

Q30394369-7BBC6728-E979-42E8-B002-9180BA80060D

Q30394369-B01E6CB5-442E-4774-A5E3-68D0932DFF5B

Q30394369-BF0C44E9-03AF-42A8-8300-BB066ACDA69C

Q30394369-C0EC827A-098E-49AE-8091-ADB44BB0C14B

Q30394369-C53E0E8E-BF6C-4E7E-98CD-40D047080BB2

Q30394369-C876B970-6DD0-4836-8B88-4C81AD9810FD

Q30394369-D757D6FE-8B2F-4DCF-B881-0D065041F0BA

Q30394369-E9338BC8-9D2E-4E1C-8F27-55801ABAAA04

P304

Q30394369-511AC598-3B25-40A3-A9D7-79DEE3C4FEC5

P31

Q30394369-9FFF91B6-E5F7-4EC8-81AA-9194D642D354

P356

Q30394369-F11CB6D2-FE53-433D-A627-C3FD7FA6C8DE

P407

Q30394369-172D370D-0417-4F8E-A8D0-0F22395A1B32

P433

Q30394369-8A293AA0-EE27-4A68-9F72-29CBD8A6A5C5

P478

Q30394369-03DE63B2-6D9E-4339-8C53-04EC51B95D13

P50

Q30394369-003B0C70-F6F4-43BA-9046-362BAF9804CF

Q30394369-375CC6CF-A3C2-419D-BB49-164D35BA7AB5

Q30394369-39D0A55C-BAA8-431E-969D-F1FBBAB111B0

Q30394369-6E114E32-2A1F-4DDB-8A02-990B5E120B0C

Q30394369-A2ED1ADD-20D6-4C84-97E2-9C37C107B89A

P577

Q30394369-BE93D171-D192-49F5-9631-8FE6A5B250D2

P5875

Q30394369-30BC1120-F5A3-41DF-A722-5B2076BBFB15

P698

Q30394369-461C5C32-B26E-416F-99F6-F4A6BEFC2B69

P921

Q30394369-809C9A6A-F213-4BEF-90F0-979565765F6F

Q30394369-95897743-981A-4407-B60E-EBA22DA0DE41

P356

P1433

Clinical Infectious Diseases

P1476

Seasonal influenza vaccine and ...... n in British Columbia, Canada.

@en

P2093

Annie Mak

http://www.w3.org/2001/XMLSchema#string

Danuta M Skowronski

http://www.w3.org/2001/XMLSchema#string

David Bowering

http://www.w3.org/2001/XMLSchema#string

Evan Adams

http://www.w3.org/2001/XMLSchema#string

Marcus Lem

http://www.w3.org/2001/XMLSchema#string

Martin Petric

http://www.w3.org/2001/XMLSchema#string

Suzana Sabaiduc

http://www.w3.org/2001/XMLSchema#string

Tracy Chan

http://www.w3.org/2001/XMLSchema#string

William Osei

http://www.w3.org/2001/XMLSchema#string

P304

1017-1027

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/656586

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P50

Naveed Zafar Janjua

Travis Salway Hottes

Gaston De Serres

David M Patrick

P577

2010-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47297796

http://www.w3.org/2001/XMLSchema#string

P698

20887210

http://www.w3.org/2001/XMLSchema#string

P921